Stonebridge Capital Advisors LLC Adamis Pharmaceuticals Corp Transaction History

Stonebridge Capital Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$0.51 - $1.26 $12,750 - $31,500	-25,000 Reduced 53.19%	22,000 $15,000
Q4 2018 Feb 13, 2019	BUY	$2.1 - $3.21 $30,450 - $46,545	14,500 Added 44.62%	47,000 $106,000
Q3 2017 Nov 15, 2017	BUY	$4.5 - $5.65 $22,500 - $28,250	5,000 Added 18.18%	32,500 $170,000
Q2 2017 Aug 15, 2017	BUY	N/A	27,500	27,500 $143,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.